Literature DB >> 24219068

An optimized protocol for overproduction of recombinant protein expression in Escherichia coli.

Elham Bahreini1, Khosrow Aghaiypour, Roghayeh Abbasalipourkabir, Mohammad Taghi Goodarzi, Massoud Saidijam, Sedigheh Sadat Safavieh.   

Abstract

The gram-negative bacterium Escherichia coli (E. coli) offers a means for rapid, high-yield, and economical production of recombinant proteins. Here, a protocol for optimization of parameters involved in bacterial expression conditions is described. L-Asparaginase (ASNase II) was chosen as a model protein for our experiments. ASNase II gene (ansB) was cloned into the pAED4 plasmid and transformed into E. coli BL21pLysS (DE3)-competent cells. It was assumed that high cell density and high copy number of recombinant plasmid in the bacteria host could result in very high production of the recombinant protein. Circumstances for the overproduction of recombinant ASNase II including cell growth conditions, isopropyl β-D-1-thiogalactopyranoside (IPTG) level, ampicillin (Amp) concentration before and during IPTG induction, and cell density were optimized. Regarding the final optimization, overexpression of ASNase II was assessed on a large scale in LB medium. Periplasmic ASNase II was extracted using an alkaline lysis method. The extracted protein was purified by one-step DEAE-Sepharose fast-flow chromatography. ASNase II activity was considered an index for the protein expression. Applying the optimized practical protocol, protein production was significantly enhanced in comparison to the traditional IPTG induction method in the absence of a fermentor and can be applied for overexpression of other recombinant proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24219068     DOI: 10.1080/10826068.2013.833116

Source DB:  PubMed          Journal:  Prep Biochem Biotechnol        ISSN: 1082-6068            Impact factor:   2.162


  4 in total

1.  L-Asparaginase from Penicillium sizovae Produced by a Recombinant Komagataella phaffii Strain.

Authors:  Marcela Freitas; Paula Souza; Mauricio Homem-de-Mello; Yris M Fonseca-Bazzo; Damaris Silveira; Edivaldo X Ferreira Filho; Adalberto Pessoa Junior; Dipak Sarker; David Timson; João Inácio; Pérola O Magalhães
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-14

2.  Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study.

Authors:  Elham Bahreini; Khosrow Aghaiypour; Roghayeh Abbasalipourkabir; Ali Rezaei Mokarram; Mohammad Taghi Goodarzi; Massoud Saidijam
Journal:  Nanoscale Res Lett       Date:  2014-07-09       Impact factor: 4.703

3.  Expression optimization of recombinant cholesterol oxidase in Escherichia coli and its purification and characterization.

Authors:  Aliakbar Fazaeli; Abolfazl Golestani; Mostafa Lakzaei; Samaneh Sadat Rasi Varaei; Mahdi Aminian
Journal:  AMB Express       Date:  2018-11-12       Impact factor: 3.298

4.  Refolding of bioactive human epidermal growth factor from E. coli BL21(DE3) inclusion bodies & evaluations on its in vitro & in vivo bioactivity.

Authors:  Iman Permana Maksum; Yosua Yosua; Ahmad Nabiel; Riyona Desvy Pratiwi; Sriwidodo Sriwidodo; Ukun M S Soedjanaatmadja
Journal:  Heliyon       Date:  2022-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.